Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Azenta ( (AZTA) ) just unveiled an announcement.
On December 29, 2025, Azenta announced that its affiliate Azenta Germany GmbH has entered into a definitive agreement to sell the company’s Luxembourg-based B Medical Systems business, a global manufacturer and distributor of medical refrigeration devices, to THELEMA S.À R.L. for US$63 million, with the transaction expected to close on or before March 31, 2026. Management described the divestiture as a major step in simplifying Azenta’s portfolio to concentrate on its highest-impact core capabilities, with proceeds earmarked to strengthen the business and support long-term profitable value creation for shareholders, while William Blair and Taylor Wessing advised Azenta on the deal.
The most recent analyst rating on (AZTA) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on Azenta stock, see the AZTA Stock Forecast page.
Spark’s Take on AZTA Stock
According to Spark, TipRanks’ AI Analyst, AZTA is a Neutral.
Azenta’s overall stock score reflects a mix of strengths and challenges. The company’s strong technical momentum and strategic share repurchase program are positive factors. However, financial performance issues, particularly in profitability and valuation, weigh on the score. The earnings call provided a cautiously optimistic outlook, but macroeconomic challenges remain a concern.
To see Spark’s full report on AZTA stock, click here.
More about Azenta
Azenta, Inc., headquartered in Burlington, Massachusetts, is a leading global provider of life sciences solutions, offering cold-chain sample management and multiomics services that support drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions across North America, Europe and Asia. The company delivers its products and services through a portfolio of established brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro and Barkey.
Average Trading Volume: 631,799
Technical Sentiment Signal: Sell
Current Market Cap: $1.6B
For detailed information about AZTA stock, go to TipRanks’ Stock Analysis page.